AstraZeneca UK Limited (primary and secondary packaging, quality control, batch release)

Ukraine

All drugs from this manufacturer

  • LYNPARZA

    The drug is prescribed for the treatment and maintenance therapy of various types of cancer, including ovarian cancer, breast cancer, pancreatic adenocarcinoma, and prostate cancer (in the presence of relevant genetic mutations, such as BRCA1/2).

    Dosage form: tablets, film-coated

    Active substance Dosage
    olaparib 100 mg

    ATC: L01XK01

  • The drug is prescribed for the treatment and maintenance therapy of various types of cancer, including ovarian cancer, breast cancer, pancreatic adenocarcinoma, and prostate cancer (in the presence of relevant genetic mutations, such as BRCA1/2).

    Dosage form: tablets, film-coated

    Active substance Dosage
    olaparib 150 mg

    ATC: L01XK01